104 related articles for article (PubMed ID: 18855157)
1. RapidArc volumetric modulated therapy planning for prostate cancer patients.
Kjaer-Kristoffersen F; Ohlhues L; Medin J; Korreman S
Acta Oncol; 2009; 48(2):227-32. PubMed ID: 18855157
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of dose painting using volumetric modulated arc optimization and delivery.
Korreman SS; Ulrich S; Bowen S; Deveau M; Bentzen SM; Jeraj R
Acta Oncol; 2010 Oct; 49(7):964-71. PubMed ID: 20831483
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dose distribution in IMRT and RapidArc technique in prostate radiotherapy.
Leszczyński W; Slosarek K; Szlag M
Rep Pract Oncol Radiother; 2012; 17(6):347-51. PubMed ID: 24377036
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes.
Yoo S; Wu QJ; Lee WR; Yin FF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):935-42. PubMed ID: 20044214
[TBL] [Abstract][Full Text] [Related]
5. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: plan quality, delivery efficiency and accuracy.
Rao M; Yang W; Chen F; Sheng K; Ye J; Mehta V; Shepard D; Cao D
Med Phys; 2010 Mar; 37(3):1350-9. PubMed ID: 20384272
[TBL] [Abstract][Full Text] [Related]
7. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment.
Quan EM; Li X; Li Y; Wang X; Kudchadker RJ; Johnson JL; Kuban DA; Lee AK; Zhang X
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1169-78. PubMed ID: 22704703
[TBL] [Abstract][Full Text] [Related]
9. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
[TBL] [Abstract][Full Text] [Related]
10. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
[TBL] [Abstract][Full Text] [Related]
11. 3D-CRT versus RapidArc in Deep Tempero-Parietal High Grade Gliomas: Do We Really Need Higher Technology?
Mashhour K; Abdelghany H; Mounir A; Hashem W
Asian Pac J Cancer Prev; 2022 Jun; 23(6):2169-2176. PubMed ID: 35763662
[TBL] [Abstract][Full Text] [Related]
12. Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer.
Jóhannesson V; Wieslander E; Nilsson P; Brun E; Bitzén U; Ahlgren G; Olsson T; Bäck S; Kjellén E; Gunnlaugsson A
Phys Imaging Radiat Oncol; 2021 Apr; 18():5-10. PubMed ID: 34258401
[TBL] [Abstract][Full Text] [Related]
13. Calculating and estimating second cancer risk from breast radiotherapy using Monte Carlo code with internal body scatter for each out-of-field organ.
Takata T; Shiraishi K; Kumagai S; Arai N; Kobayashi T; Oba H; Okamoto T; Kotoku J
J Appl Clin Med Phys; 2020 Dec; 21(12):62-73. PubMed ID: 33128332
[TBL] [Abstract][Full Text] [Related]
14. Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation.
Haciislamoglu E; Gungor G; Aydin G; Canyilmaz E; Guler OC; Zengin AY; Yenice KM
J Appl Clin Med Phys; 2020 Sep; 21(9):82-89. PubMed ID: 32671989
[TBL] [Abstract][Full Text] [Related]
15. The impact of the field width on VMAT plan quality and the assessment of half field method.
Ugurlu BT; Temelli O
J Appl Clin Med Phys; 2020 Mar; 21(3):115-122. PubMed ID: 32077576
[TBL] [Abstract][Full Text] [Related]
16. Is High Definition MLC Dosimetrically Superior to Standard Definition MLC for SIB-SBRT for Carcinoma Prostate.
T K B; Ganesh KM; A P
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3817-3823. PubMed ID: 31870127
[TBL] [Abstract][Full Text] [Related]
17. Performance of the eclipse monitor unit objective tool utilizing volumetric modulated arc therapy for rectal cancer.
Prado A; Gaitán Á; Leonor M; Manzano M; Cabello E; Díaz R; Ferrando A; Milanés A; Pozo G
Rep Pract Oncol Radiother; 2019; 24(2):227-232. PubMed ID: 30858766
[TBL] [Abstract][Full Text] [Related]
18. Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots.
Nguyen TTT; Arimura H; Asamura R; Hirose TA; Ohga S; Fukunaga JI
Radiol Phys Technol; 2019 Jun; 12(2):137-148. PubMed ID: 30805779
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric effect of limited aperture multileaf collimator on VMAT plan quality: A study of prostate and head-and-neck cancers.
Murtaza G; Mehmood S; Rasul S; Murtaza I; Khan EU
Rep Pract Oncol Radiother; 2018; 23(3):189-198. PubMed ID: 29760593
[TBL] [Abstract][Full Text] [Related]
20. Optimal collimator rotation based on the outline of multiple brain targets in VMAT.
Kim JI; Ahn BS; Choi CH; Park JM; Park SY
Radiat Oncol; 2018 May; 13(1):88. PubMed ID: 29739431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
